3835 related articles for article (PubMed ID: 11335776)
1. The effects of metformin on body mass index and glucose tolerance in obese adolescents with fasting hyperinsulinemia and a family history of type 2 diabetes.
Freemark M; Bursey D
Pediatrics; 2001 Apr; 107(4):E55. PubMed ID: 11335776
[TBL] [Abstract][Full Text] [Related]
2. Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.
Pasquali R; Gambineri A; Biscotti D; Vicennati V; Gagliardi L; Colitta D; Fiorini S; Cognigni GE; Filicori M; Morselli-Labate AM
J Clin Endocrinol Metab; 2000 Aug; 85(8):2767-74. PubMed ID: 10946879
[TBL] [Abstract][Full Text] [Related]
3. Beneficial effects of metformin in normoglycemic morbidly obese adolescents.
Kay JP; Alemzadeh R; Langley G; D'Angelo L; Smith P; Holshouser S
Metabolism; 2001 Dec; 50(12):1457-61. PubMed ID: 11735093
[TBL] [Abstract][Full Text] [Related]
4. A randomized, double-blind, placebo-controlled trial of metformin treatment of weight gain associated with initiation of atypical antipsychotic therapy in children and adolescents.
Klein DJ; Cottingham EM; Sorter M; Barton BA; Morrison JA
Am J Psychiatry; 2006 Dec; 163(12):2072-9. PubMed ID: 17151157
[TBL] [Abstract][Full Text] [Related]
5. Use of metformin in obese adolescents with hyperinsulinemia: a 6-month, randomized, double-blind, placebo-controlled clinical trial.
Atabek ME; Pirgon O
J Pediatr Endocrinol Metab; 2008 Apr; 21(4):339-48. PubMed ID: 18556965
[TBL] [Abstract][Full Text] [Related]
6. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
DeFronzo RA; Barzilai N; Simonson DC
J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
[TBL] [Abstract][Full Text] [Related]
7. Liver dysfunction in paediatric obesity: a randomized, controlled trial of metformin.
Freemark M
Acta Paediatr; 2007 Sep; 96(9):1326-32. PubMed ID: 17718786
[TBL] [Abstract][Full Text] [Related]
8. Intensive insulin therapy combined with metformin in obese type 2 diabetic patients.
Fritsche A; Schmülling RM; Häring HU; Stumvoll M
Acta Diabetol; 2000 Mar; 37(1):13-8. PubMed ID: 10928231
[TBL] [Abstract][Full Text] [Related]
9. The effects of rosiglitazone and metformin on insulin resistance and serum androgen levels in obese and lean patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Karakoç A; Törüner F; Bingöl B; Cakir N; Tiras B; Ayvaz G; Arslan M
J Endocrinol Invest; 2005 Dec; 28(11):1003-8. PubMed ID: 16483179
[TBL] [Abstract][Full Text] [Related]
10. Retrospective Evaluation of Metformin and/or Metformin Plus a New Polysaccharide Complex in Treating Severe Hyperinsulinism and Insulin Resistance in Obese Children and Adolescents with Metabolic Syndrome.
Stagi S; Ricci F; Bianconi M; Sammarco MA; Municchi G; Toni S; Lenzi L; Verrotti A; de Martino M
Nutrients; 2017 May; 9(5):. PubMed ID: 28531113
[No Abstract] [Full Text] [Related]
11. Metformin reduces weight, centripetal obesity, insulin, leptin, and low-density lipoprotein cholesterol in nondiabetic, morbidly obese subjects with body mass index greater than 30.
Glueck CJ; Fontaine RN; Wang P; Subbiah MT; Weber K; Illig E; Streicher P; Sieve-Smith L; Tracy TM; Lang JE; McCullough P
Metabolism; 2001 Jul; 50(7):856-61. PubMed ID: 11436194
[TBL] [Abstract][Full Text] [Related]
12. Rosiglitazone is more effective than metformin in improving fasting indexes of glucose metabolism in severely obese, non-diabetic patients.
Brunani A; Caumo A; Graci S; Castagna G; Viberti G; Liuzzi A
Diabetes Obes Metab; 2008 Jun; 10(6):460-7. PubMed ID: 17394563
[TBL] [Abstract][Full Text] [Related]
13. Variation in inflammatory markers and glycemic parameters after 12 months of exenatide plus metformin treatment compared with metformin alone: a randomized placebo-controlled trial.
Derosa G; Franzetti IG; Querci F; Carbone A; Ciccarelli L; Piccinni MN; Fogari E; Maffioli P
Pharmacotherapy; 2013 Aug; 33(8):817-26. PubMed ID: 23744726
[TBL] [Abstract][Full Text] [Related]
14. Metformin for overweight women at midlife: a double-blind, randomized, controlled trial.
Worsley R; Jane F; Robinson PJ; Bell RJ; Davis SR
Climacteric; 2015 Apr; 18(2):270-7. PubMed ID: 25333776
[TBL] [Abstract][Full Text] [Related]
15. Effects of short-term metformin treatment on insulin sensitivity of blood glucose and free fatty acids.
Iannello S; Camuto M; Cavaleri A; Milazzo P; Pisano MG; Bellomia D; Belfiore F
Diabetes Obes Metab; 2004 Jan; 6(1):8-15. PubMed ID: 14686957
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group.
DeFronzo RA; Goodman AM
N Engl J Med; 1995 Aug; 333(9):541-9. PubMed ID: 7623902
[TBL] [Abstract][Full Text] [Related]
17. Metformin reduces body weight gain and improves glucose intolerance in high-fat diet-fed C57BL/6J mice.
Matsui Y; Hirasawa Y; Sugiura T; Toyoshi T; Kyuki K; Ito M
Biol Pharm Bull; 2010; 33(6):963-70. PubMed ID: 20522960
[TBL] [Abstract][Full Text] [Related]
18. Metformin therapy in obese adolescents with polycystic ovary syndrome and impaired glucose tolerance: amelioration of exaggerated adrenal response to adrenocorticotropin with reduction of insulinemia/insulin resistance.
Arslanian SA; Lewy V; Danadian K; Saad R
J Clin Endocrinol Metab; 2002 Apr; 87(4):1555-9. PubMed ID: 11932281
[TBL] [Abstract][Full Text] [Related]
19. Effects of metformin administration on endocrine-metabolic parameters, visceral adiposity and cardiovascular risk factors in children with obesity and risk markers for metabolic syndrome: A pilot study.
Bassols J; Martínez-Calcerrada JM; Osiniri I; Díaz-Roldán F; Xargay-Torrent S; Mas-Parés B; Dorado-Ceballos E; Prats-Puig A; Carreras-Badosa G; de Zegher F; Ibáñez L; López-Bermejo A
PLoS One; 2019; 14(12):e0226303. PubMed ID: 31821361
[TBL] [Abstract][Full Text] [Related]
20. Insulin resistance and impaired glucose tolerance in obese children and adolescents referred to a tertiary-care center in Israel.
Shalitin S; Abrahami M; Lilos P; Phillip M
Int J Obes (Lond); 2005 Jun; 29(6):571-8. PubMed ID: 15889115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
